Analgesic efficacy, safety, and tolerability of a long-acting abuse-deterrent formulation of oxycodone for moderate-to-severe chronic low back pain in subjects successfully switched from immediate-release oxycodone

OBJECTIVES: This post hoc analysis of data from a randomized, double-blind, placebo-controlled, enriched-enrollment randomized-withdrawal Phase III study evaluated the safety, tolerability, and analgesic efficacy of Oxycodone DETERx extended-release (ER), abuse-deterrent capsules (Xtampza(®) ER) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Markman, John, Meske, Diana S, Kopecky, Ernest A, Vaughn, Ben, O’Connor, Melinda L, Passik, Steven D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163025/
https://www.ncbi.nlm.nih.gov/pubmed/30288095
http://dx.doi.org/10.2147/JPR.S168836

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163025/
https://www.ncbi.nlm.nih.gov/pubmed/30288095
http://dx.doi.org/10.2147/JPR.S168836

Ejemplares similares